Repartition of the 28 148 classified lymphomas after pathologic review, according to sampling procedures
| Expert diagnoses (n = 28 148) . | CNB (n = 8779) . | Surgical excision (n = 19 369) . | P . |
|---|---|---|---|
| Classified B-cell lymphoma (n = 19 347) | 6574 (74.9%) | 12 773 (65.9%) | <.0001 |
| Aggressive B-NHL | 3090 (35.2%) | 4662 (24.1%) | |
| Indolent B-NHL | 3484 (39.7%) | 8111 (41.9%) | |
| Classified peripheral T-cell lymphoma (n = 2201) | 565 (6.4%) | 1636 (8.5%) | <.0001 |
| Classified HL (n = 6600) | 1640 (18.7%) | 4960 (25.6%) | <.0001 |
| Classical HL | 1511 (17.2%) | 4297 (22.2%) | |
| Nodular lymphocyte predominant HL | 129 (1.5%) | 663 (3.4%) |
| Expert diagnoses (n = 28 148) . | CNB (n = 8779) . | Surgical excision (n = 19 369) . | P . |
|---|---|---|---|
| Classified B-cell lymphoma (n = 19 347) | 6574 (74.9%) | 12 773 (65.9%) | <.0001 |
| Aggressive B-NHL | 3090 (35.2%) | 4662 (24.1%) | |
| Indolent B-NHL | 3484 (39.7%) | 8111 (41.9%) | |
| Classified peripheral T-cell lymphoma (n = 2201) | 565 (6.4%) | 1636 (8.5%) | <.0001 |
| Classified HL (n = 6600) | 1640 (18.7%) | 4960 (25.6%) | <.0001 |
| Classical HL | 1511 (17.2%) | 4297 (22.2%) | |
| Nodular lymphocyte predominant HL | 129 (1.5%) | 663 (3.4%) |